HS-438
HS-438 is a potent and selective BCR-ABL inhibitor. HS-438 shows antiproliferative activity. HS-438 decreases the expression of phosphorylation of BCR-ABL (Tyr177) . HS-438 induces apoptosis and cell cycle arrest at G0/G1 phase. HS-438 shows antitumor activity. HS-438 has the potential for the research of chronic myeloid leukemia (CML) [1].
Product Specifications
CAS Number
1430720-10-7
UNSPSC
12352005
Target
Apoptosis; Bcr-Abl
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hs-438.html
Smiles
O=C(NCCO)NC1=NC2=CC=C(C=C2S1)C3=CC=CC=C3OC
Molecular Formula
C17H17N3O3S
Molecular Weight
343.40
References & Citations
[1]Yun SM, et al. HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Cancer Lett. 2014 Jun 28;348 (1-2) :50-60.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1602357 100 µL
PCV2 capsid protein Rabbit Polyclonal Antibody (AP)
Sign In for Pricing
View Details